This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

5j1v

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Current revision

Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW29 (compound 13)

Structural highlights

5j1v is a 3 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:	X-ray diffraction, Resolution 2.52Å
Ligands:	,
Resources:	FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

CLK1_HUMAN Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA.^[1] ^[2]

Publication Abstract from PubMed

The design and synthesis of new pyrido[3,4-g]quinazoline derivatives is described as well as their protein kinase inhibitory potencies toward five CMGC family members (CDK5, CK1, GSK3, CLK1 and DYRK1A). The interest for this original tricyclic heteroaromatic scaffold as modulators of CLK1/DYRK1A activity was validated by nanomolar potencies (compounds 12 and 13). CLK1 co-crystal structures with two inhibitors revealed the binding mode of these compounds within the ATP-binding pocket.

Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure.,Esvan YJ, Zeinyeh W, Boibessot T, Nauton L, Thery V, Knapp S, Chaikuad A, Loaec N, Meijer L, Anizon F, Giraud F, Moreau P Eur J Med Chem. 2016 Apr 5;118:170-177. doi: 10.1016/j.ejmech.2016.04.004. PMID:27128181^[3]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

↑ Moeslein FM, Myers MP, Landreth GE. The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the tyrosine phosphatase, PTP-1B. J Biol Chem. 1999 Sep 17;274(38):26697-704. PMID:10480872
↑ Eisenreich A, Bogdanov VY, Zakrzewicz A, Pries A, Antoniak S, Poller W, Schultheiss HP, Rauch U. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells. Circ Res. 2009 Mar 13;104(5):589-99. doi: 10.1161/CIRCRESAHA.108.183905. Epub, 2009 Jan 22. PMID:19168442 doi:10.1161/CIRCRESAHA.108.183905
↑ Esvan YJ, Zeinyeh W, Boibessot T, Nauton L, Thery V, Knapp S, Chaikuad A, Loaec N, Meijer L, Anizon F, Giraud F, Moreau P. Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure. Eur J Med Chem. 2016 Apr 5;118:170-177. doi: 10.1016/j.ejmech.2016.04.004. PMID:27128181 doi:http://dx.doi.org/10.1016/j.ejmech.2016.04.004

1 Structural highlights
2 Function
3 Publication Abstract from PubMed
4 See Also
5 References

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/5j1v"

@@ Line 1: / Line 1: @@
 ==Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW29 (compound 13)==
-<StructureSection load='5j1v' size='340' side='right' caption='[[5j1v]], [[Resolution|resolution]] 2.52&Aring;' scene=''>
+<StructureSection load='5j1v' size='340' side='right'caption='[[5j1v]], [[Resolution|resolution]] 2.52&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[5j1v]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5J1V OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5J1V FirstGlance]. <br>
+<table><tr><td colspan='2'>[[5j1v]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5J1V OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5J1V FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6FD:PYRIDO[3,4-G]QUINAZOLINE-2,10-DIAMINE'>6FD</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.52&#8491;</td></tr>
-<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dual-specificity_kinase Dual-specificity kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.12.1 2.7.12.1] </span></td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6FD:PYRIDO[3,4-G]QUINAZOLINE-2,10-DIAMINE'>6FD</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5j1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5j1v OCA], [http://pdbe.org/5j1v PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5j1v RCSB], [http://www.ebi.ac.uk/pdbsum/5j1v PDBsum]</span></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5j1v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5j1v OCA], [https://pdbe.org/5j1v PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5j1v RCSB], [https://www.ebi.ac.uk/pdbsum/5j1v PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5j1v ProSAT]</span></td></tr>
 </table>
 == Function ==
-[[http://www.uniprot.org/uniprot/CLK1_HUMAN CLK1_HUMAN]] Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA.<ref>PMID:10480872</ref> <ref>PMID:19168442</ref>
+[https://www.uniprot.org/uniprot/CLK1_HUMAN CLK1_HUMAN] Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA.<ref>PMID:10480872</ref> <ref>PMID:19168442</ref>
 <div style="background-color:#fffaf0;">
 == Publication Abstract from PubMed ==
@@ Line 19: / Line 19: @@
 </div>
 <div class="pdbe-citations 5j1v" style="background-color:#fffaf0;"></div>
+==See Also==
+*[[Dual specificity protein kinase 3D structures|Dual specificity protein kinase 3D structures]]
 == References ==
 <references/>
 __TOC__
 </StructureSection>
-[[Category: Dual-specificity kinase]]
+[[Category: Homo sapiens]]
-[[Category: Anizon, F]]
+[[Category: Large Structures]]
-[[Category: Arrowsmith, C H]]
+[[Category: Anizon F]]
-[[Category: Boibessot, T]]
+[[Category: Arrowsmith CH]]
-[[Category: Bountra, C]]
+[[Category: Boibessot T]]
-[[Category: Chaikuad, A]]
+[[Category: Bountra C]]
-[[Category: Delft, F von]]
+[[Category: Chaikuad A]]
-[[Category: Edwards, A M]]
+[[Category: Edwards AM]]
-[[Category: Esvan, Y J]]
+[[Category: Esvan YJ]]
-[[Category: Giraud, F]]
+[[Category: Giraud F]]
-[[Category: Knapp, S]]
+[[Category: Knapp S]]
-[[Category: Loaec, N]]
+[[Category: Loaec N]]
-[[Category: Meijer, L]]
+[[Category: Meijer L]]
-[[Category: Moreau, P]]
+[[Category: Moreau P]]
-[[Category: Nauton, L]]
+[[Category: Nauton L]]
-[[Category: Structural genomic]]
+[[Category: Thery V]]
-[[Category: Thery, V]]
+[[Category: Zeinyeh W]]
-[[Category: Zeinyeh, W]]
+[[Category: Von Delft F]]
-[[Category: Inhibitor]]
-[[Category: Nucleus]]
-[[Category: Serine/threonine-protein kinase]]
-[[Category: Sgc]]
-[[Category: Transferase]]
-[[Category: Tyrosine-protein kinase]]

5j1v

From Proteopedia

Current revision

Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW29 (compound 13)

Structural highlights

Function

Publication Abstract from PubMed

See Also

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox